Form 144: Morgan Stanley files to sell 18,673 CGNX shares
Morgan Stanley Smith Barney LLC filed a Form 144 reporting the proposed sale of Common Stock of CGNX tied to a stock option exercise for 18,673 shares scheduled on 05/27/2026.
Rhea-AI Filing Summary
Morgan Stanley Smith Barney LLC filed a Form 144 reporting the proposed sale of Common Stock of CGNX tied to a stock option exercise for 18,673 shares scheduled on 05/27/2026. The filing also lists prior restricted stock grants dated 02/16/2022, 02/16/2023, and 02/18/2023 with 145, 216, and 1,218 shares respectively.
Positive
- None.
Negative
- None.
Insights
Form 144 lists an intended sale of 18,673 CGNX shares via option exercise on 05/27/2026.
The filing shows the method as a Stock Option Exercise with the seller identified as Morgan Stanley Smith Barney LLC Executive Financial Services. The notice is procedural and consistent with Rule 144 resale reporting.
Timing and proceeds treatment are governed by the Rule 144 notice; subsequent transaction consummation and settlement details will appear in later transfer or broker reports.
Key Figures
Key Terms
Form 144 regulatory
Stock Option Exercise financial
Restricted Stock financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does the Form 144 for CGNX report?
Who is the filer on the CGNX Form 144?
Are there other securities or grants listed in the filing?
Does Form 144 confirm the sale was completed?
What regulatory rule governs this filing?
AI-generated analysis. How Rhea-AI works. Not financial advice.